profit from every $100 of sales.
$0$100
SRx Health Solutions
$0.87+7.20% today
+1,044.7% in 1 year
1-year low $0.061-year high $4.04
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What SRx Health Solutions sold, what it kept, and what it did with the cash.
Sales went from $0 in 2024 to $6.53 million in 2025, with -$45.0 million of profit last year.
SalesProfit
SRx Health Solutions vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| SRx Health Solutions | No profit yet | ||
 Eli Lilly | 60.9× · Very expensive | ||
 Johnson & Johnson | 25.3× · Fair price | ||
 AbbVie | 122.7× · Very expensive | ||
 Roche | 25.4× · Fair price |
AI analysis
An AI analyst reads SRx Health Solutions's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2024 | 2025 |
|---|---|---|
| 0 | 7 | |
| 0 | 2 | |
| 0 | -11 | |
| 4 | -8 | |
| -43 | -45 | |
| -3.01 | -1.81 | |
| – | 23.4% | |
| – | -174.6% | |
| – | -688.8% |
Balance sheet
| In millions of USD | 2024 | 2025 |
|---|---|---|
| Total assets | 34 | 8 |
| Cash | 0 | 1 |
| Total debt | 45 | 4 |
| Total liabilities | 89 | 8 |
| -55 | 0 | |
| 14 | 25 | |
| – | -129.7% | |
| 78.1% | -11,058.0% |
Cash flow
| In millions of USD | 2024 | 2025 |
|---|---|---|
| -1 | -8 | |
| – | 2 | |
| -1 | -10 | |
| Dividends paid | – | – |
| 0 | 0 | |
| 4 | 3 |
Valuation
- –
- 0.5×
- –
- 1.1×
- 2.7×
- –
- –
- -58.2%
- -256.3%
- 0.0%
Profitability
- 23.4%
- -174.6%
- -688.8%
- 282.8%
- 5.4%
- -143.6%
- 435.9%
- -146.7%
- 37.4%
- –
Growth
- −38.6%
- –
- −150.1%
- –
- +161.3%
Financial health
- –
- 5.97
- 77.7%
- 0.4×
- 0.80
- 0.74
- -0.49
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 49%of 948
Bottom 1%of 871
Bottom 2%of 868
Bottom 1%of 985
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 14, 2026 | -0.02 | -0.26 | +92.3% |
| Feb 13, 2026 | -0.17 | – | – |
| Nov 10, 2025 | -0.40 | – | – |
| Sep 30, 2025 | -0.74 | – | – |
| May 15, 2025 | -0.37 | – | – |
| Mar 27, 2025 | -0.50 | -4.84 | +89.7% |
| Nov 12, 2024 | -0.54 | -2.20 | +75.5% |
| Jun 30, 2024 | -0.10 | -2.20 | +95.3% |
News
Obamacare Subsidies Lapsed. Here's Why Health Insurer Stocks Are Watching the New Congress.Yahoo Finance · Nov 8, 2026Notable healthcare headlines for the week: Moderna, Pfizer, and CVS Health in focusSeeking Alpha · Nov 8, 2026The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?Yahoo Finance · Nov 7, 2026What Did CVS Health's Quarter Change For Its Stock?Yahoo Finance · Nov 7, 2026Evolent Health, Inc. Q3 2026 Earnings Call SummaryYahoo Finance · Nov 5, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
4No pass
Benjamin Graham
30No pass
Philip Fisher
19No pass
Peter Lynch
0No pass
Joel Greenblatt
1No pass
Charlie Munger
7No pass
Terry Smith
5No pass
Questions about SRx Health Solutions
Is SRx Health Solutions a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the SRx Health Solutions AI analysis
What does SRx Health Solutions do?
SRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The company offers comprehensive, integrated, and customized specialty healthcare services across all ten Canadian provinces. It is in Drug Manufacturers - General.
Does SRx Health Solutions pay a dividend?
No. SRx Health Solutions does not pay a dividend at the moment; in 2025 it returned $137,000 to shareholders by buying back its own shares.
Is SRx Health Solutions stock halal?
Yes. SRx Health Solutions passes our halal screen: its business is permitted and its debt is 25% of its market value, under the 30% limit. How we check
How has SRx Health Solutions stock done over the past year?
Up 1,044.7% over the past twelve months, to $0.87. It traded between $0.06 and $4.04 and is 78.5% below its high.
Who are SRx Health Solutions's competitors?
The largest listed companies in the same industry are Eli Lilly, Johnson & Johnson, AbbVie and Roche. The peers table on this page compares their profit, growth and price with SRx Health Solutions's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.